Literature DB >> 19542771

Pain management during retinopathy of prematurity eye examinations: a systematic review.

Haifa A Samra1, Jacqueline M McGrath.   

Abstract

Retinopathy of prematurity (ROP) remains a concern for many preterm infants. Early detection and timely treatment have been shown to be effective in improving visual outcomes; moreover, it is crucial that a series of indirect ophthalmic examinations be performed until an infant is considered no longer at risk for the disease. The purpose of this systematic review is to summarize and evaluate the published evidence regarding characteristics and effectiveness of pain management interventions during the ROP examination. Implications for practice are discussed and suggestions for further research are made. Despite the general consensus that ROP examination is a painful procedure with considerable amount of discomfort, evidence shows that pain management during the ROP examination is inadequate. Although there are currently clear recommendations and guidelines for performing the ROP examination, there are no standard protocols for pharmacological and nonpharmacological pain management during the ROP examination. This is an area where much work is still needed to address the needs of the infant during this critical examination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542771     DOI: 10.1097/ANC.0b013e3181a68b48

Source DB:  PubMed          Journal:  Adv Neonatal Care        ISSN: 1536-0903            Impact factor:   1.968


  11 in total

1.  Evaluation of retinopathy of prematurity screening in reverse Kangaroo Mother Care: a pilot study.

Authors:  T R Padhi; D Sareen; L Pradhan; S Jalali; S Sutar; T Das; R R Modi; U C Behera
Journal:  Eye (Lond)       Date:  2015-01-23       Impact factor: 3.775

2.  Safety of Retinopathy of Prematurity Examination and Imaging in Premature Infants.

Authors:  Kelly C Wade; Maxwell Pistilli; Agnieshka Baumritter; Karen Karp; Alice Gong; Alex R Kemper; Gui-Shuang Ying; Graham Quinn
Journal:  J Pediatr       Date:  2015-08-20       Impact factor: 4.406

3.  Physiologic effects of retinopathy of prematurity screening examinations.

Authors:  Anita J Mitchell; Angela Green; Debra A Jeffs; Paula K Roberson
Journal:  Adv Neonatal Care       Date:  2011-08       Impact factor: 1.968

4.  Comparison of RetCam and Smartphone-Based Photography for Retinopathy of Prematurity Screening.

Authors:  Jui-Yen Lin; Eugene Yu-Chuan Kang; Alay S Banker; Kuan-Jen Chen; Yih-Shiou Hwang; Chi-Chun Lai; Jhen-Ling Huang; Wei-Chi Wu
Journal:  Diagnostics (Basel)       Date:  2022-04-10

5.  Retinopathy of prematurity: An update on screening and management.

Authors:  Ann L Jefferies
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

6.  The pain response to mydriatic eyedrops in preterm infants.

Authors:  A M Cohen; N Cook; M C Harris; G-S Ying; G Binenbaum
Journal:  J Perinatol       Date:  2012-12-13       Impact factor: 2.521

7.  Predictive Value of Pupillary Response to Mydriatic Agents for Diagnosis of Retinopathy of Prematurity.

Authors:  Ramak Roohipoor; Mohammad Riazi-Esfahani; Nazanin Ebrahimiadib; Reza Karkhaneh; Mohammad Zarei; Sara Besharat; Fariba Ghassemi; Mohammad Reza Ostovaneh
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

8.  Differential effects of the retinopathy of prematurity exam on the physiology of premature infants.

Authors:  John B C Tan; Jennifer Dunbar; Andrew Hopper; Christopher G Wilson; Danilyn M Angeles
Journal:  J Perinatol       Date:  2019-02-12       Impact factor: 2.521

9.  Assessment of WINROP algorithm as screening tool for preterm infants in Manitoba to detect retinopathy of prematurity.

Authors:  Ebtihal Ali; Nasser Al-Shafouri; Abrar Hussain; R John Baier
Journal:  Paediatr Child Health       Date:  2017-05-08       Impact factor: 2.253

10.  Oral glucose for pain relief during examination for retinopathy of prematurity: a masked randomized clinical trial.

Authors:  Marlene Coelho da Costa; Gabriela Unchalo Eckert; Barbara Gastal Borges Fortes; João Borges Fortes Filho; Rita C Silveira; Renato S Procianoy
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.